Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-24-000041
Filing Date
2024-08-05
Accepted
2024-08-05 16:22:38
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20240630.htm   iXBRL 10-Q 1345951
2 EX-10.29 redactedsagard-anaptysbiof.htm EX-10.29 83474
3 EX-31.1 anab-6302024x10qxexx311.htm EX-31.1 8452
4 EX-31.2 anab-6302024x10qxexx312.htm EX-31.2 8303
5 EX-32.1 anab-6302024x10qxexx321.htm EX-32.1 4972
6 EX-32.2 anab-6302024x10qxexx322.htm EX-32.2 4864
12 PIPELINE CHART anab-20240630_g1.jpg GRAPHIC 151625
  Complete submission text file 0001370053-24-000041.txt   7334695

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20240630.xsd EX-101.SCH 51216
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20240630_cal.xml EX-101.CAL 55225
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20240630_def.xml EX-101.DEF 203525
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20240630_lab.xml EX-101.LAB 617610
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20240630_pre.xml EX-101.PRE 407763
72 EXTRACTED XBRL INSTANCE DOCUMENT anab-20240630_htm.xml XML 975519
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

EIN.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 241175118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)